Corteva, Inc. $CTVA Shares Sold by Dimensional Fund Advisors LP

Dimensional Fund Advisors LP decreased its holdings in Corteva, Inc. (NYSE:CTVA) by 3.7% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,667,215 shares of the company’s stock after selling 177,525 shares during the period. Dimensional Fund Advisors LP owned about 0.69% of Corteva worth $315,647,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also modified their holdings of CTVA. Brighton Jones LLC increased its holdings in Corteva by 307.2% during the 4th quarter. Brighton Jones LLC now owns 15,588 shares of the company’s stock worth $888,000 after purchasing an additional 11,760 shares during the period. Woodline Partners LP raised its holdings in Corteva by 40.3% in the first quarter. Woodline Partners LP now owns 57,919 shares of the company’s stock valued at $3,645,000 after acquiring an additional 16,644 shares in the last quarter. Ellevest Inc. raised its holdings in Corteva by 11.2% in the second quarter. Ellevest Inc. now owns 5,414 shares of the company’s stock valued at $404,000 after acquiring an additional 544 shares in the last quarter. Atlantic Union Bankshares Corp purchased a new position in Corteva in the second quarter worth approximately $1,386,000. Finally, Resona Asset Management Co. Ltd. grew its holdings in Corteva by 3.9% during the 2nd quarter. Resona Asset Management Co. Ltd. now owns 226,584 shares of the company’s stock worth $16,883,000 after acquiring an additional 8,606 shares in the last quarter. 81.54% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Corteva

In other news, insider Brian Titus sold 8,311 shares of the stock in a transaction dated Friday, February 20th. The shares were sold at an average price of $76.55, for a total transaction of $636,207.05. Following the completion of the sale, the insider owned 8,090 shares in the company, valued at approximately $619,289.50. This represents a 50.67% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.14% of the company’s stock.

Corteva Stock Down 1.8%

Shares of NYSE CTVA opened at $76.57 on Friday. The business has a 50-day moving average price of $72.81 and a 200 day moving average price of $69.02. The stock has a market cap of $51.49 billion, a PE ratio of 48.46, a price-to-earnings-growth ratio of 2.67 and a beta of 0.72. The company has a quick ratio of 0.96, a current ratio of 1.43 and a debt-to-equity ratio of 0.07. Corteva, Inc. has a 52-week low of $53.40 and a 52-week high of $80.90.

Corteva (NYSE:CTVA) last issued its quarterly earnings data on Tuesday, February 3rd. The company reported $0.22 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.22. The company had revenue of $3.91 billion during the quarter, compared to analysts’ expectations of $4.23 billion. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The firm’s revenue for the quarter was down 1.7% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.32 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Equities research analysts forecast that Corteva, Inc. will post 2.96 earnings per share for the current year.

Corteva Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 16th. Shareholders of record on Monday, March 2nd will be paid a $0.18 dividend. The ex-dividend date is Monday, March 2nd. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. Corteva’s payout ratio is currently 45.57%.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on CTVA. Rothschild & Co Redburn reduced their price objective on shares of Corteva from $71.00 to $65.00 and set a “neutral” rating on the stock in a report on Tuesday, November 11th. Oppenheimer set a $86.00 price target on Corteva in a research note on Thursday, February 5th. Wolfe Research upped their price objective on Corteva from $81.00 to $86.00 and gave the stock an “outperform” rating in a research report on Thursday, February 5th. Citigroup increased their price objective on Corteva from $74.00 to $80.00 and gave the company a “neutral” rating in a report on Thursday, February 5th. Finally, Deutsche Bank Aktiengesellschaft upped their price target on Corteva from $85.00 to $90.00 and gave the company a “buy” rating in a report on Thursday, February 5th. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and eight have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $82.80.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.